Cartox
In vitro cardiotoxicity testing platform using mature human stem cell derived cardiomyocytes
ExoDynamics
Smart, active spinal orthoses that provides support and mobility to users
MEKanistic Therapeutics
MEKanistic is innovating cancer therapies by advancing a novel class of selective kinase inhibitors rationally designed to target both EGFR and PI3K with a single molecule. This breakthrough design expands the therapeutic window while avoiding inherent toxicity challenges of multi-compound treatments. Preclinical studies of its lead drug MTX-531 show a high incidence of tumor regression with dramatically reduced toxicity.
